Polycomb repressive complex 2 (PRC2) places H3K27me3 at developmental genes and is causally implicated in keeping bivalent genes silent. It is unclear if that silence requires minimum H3K27me3 levels and how the mark transmits faithfully across mammalian somatic cell generations. Mouse intestinal cells lacking EZH2 methyltransferase reduce H3K27me3 proportionately at all PRC2 target sites, but ∼40% uniform residual levels keep target genes inactive. These genes, derepressed in PRC2-null villus cells, remain silent in intestinal stem cells (ISCs). Quantitative chromatin immunoprecipitation and computational modeling indicate that because unmodified histones dilute H3K27me3 by 50% each time DNA replicates, PRC2-deficient ISCs initially retain sufficient H3K27me3 to avoid gene derepression. EZH2 mutant human lymphoma cells also require multiple divisions before H3K27me3 dilution relieves gene silencing. In both cell types, promoters with high basal H3K4me2/3 activate in spite of some residual H3K27me3, compared to less-poised promoters. These findings have implications for PRC2 inhibition in cancer therapy.
Keywords: Ezh2; PRC2; epigenetic memory; gene repression; poised promoters.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
PRC2 represses transcribed genes on the imprinted inactive X chromosome in mice.Genome Biol. 2017 May 3;18(1):82. doi: 10.1186/s13059-017-1211-5. Genome Biol. 2017. PMID: 28468635 Free PMC article.
A model for transmission of the H3K27me3 epigenetic mark.Nat Cell Biol. 2008 Nov;10(11):1291-300. doi: 10.1038/ncb1787. Epub 2008 Oct 19. Nat Cell Biol. 2008. PMID: 18931660
Transcription factor-dependent 'anti-repressive' mammalian enhancers exclude H3K27me3 from extended genomic domains.Genes Dev. 2017 Dec 1;31(23-24):2391-2404. doi: 10.1101/gad.308536.117. Epub 2018 Jan 10. Genes Dev. 2017. PMID: 29321178 Free PMC article.
Mitotic Inheritance of PRC2-Mediated Silencing: Mechanistic Insights and Developmental Perspectives.Front Plant Sci. 2020 Mar 9;11:262. doi: 10.3389/fpls.2020.00262. eCollection 2020. Front Plant Sci. 2020. PMID: 32211012 Free PMC article. Review.
Targeting EZH2 and PRC2 dependence as novel anticancer therapy.Exp Hematol. 2015 Aug;43(8):698-712. doi: 10.1016/j.exphem.2015.05.001. Epub 2015 May 28. Exp Hematol. 2015. PMID: 26027790 Free PMC article. Review.